as on November 11, 2025 at 2:29 am IST
Day's Low
Day's High
1.30%
Downside
0.75%
Upside
52 Week's Low
52 Week's High
21.76%
Downside
3.75%
Upside
Check Amgen Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$172.4B
EPS (TTM)
21.1885
Dividend Yield
2.63%
Quarterly Earnings Growth YOY
0.14%
PE Ratio (TTM)
24.75
Industry PE ratio
19.200384615384614
PEG Ratio
0.9577
EBITDA
16.5B
Revenue (TTM)
36.0B
Profit Margin
19.47%
Return On Equity TTM
81.71%
Track how Amgen Inc. P/E has moved over time to understand its valuation trends.
Amgen Inc. in the last 5 years
Lowest (12.34x)
December 31, 2021
Industry (19.20x)
November 10, 2025
Today (24.75x)
November 10, 2025
Highest (17.02x)
September 30, 2024
Today’s Price to Earnings Ratio: 24.75x
Compare market cap, revenue, PE, and other key metrics of Amgen Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $172.4B | 32.53% | 24.75 | 19.47% | |
| BUY | $828.7B | 530.71% | 45.25 | 30.99% | |
| BUY | $387.3B | 121.66% | 167.3 | 4.00% | |
| BUY | $449.5B | 25.82% | 18.03 | 27.26% | |
| BUY | $214.1B | 6.37% | 11.41 | 29.63% |
The Amgen Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Amgen Inc. investment value today
Current value as on today
₹1,04,691
Returns
₹4,691
(+4.69%)
Returns from Amgen Inc. Stock
Dollar Returns*
₹5,165 (+5.16%)
Based on 37 analysts
56.76%
Buy
35.14%
Hold
8.11%
Sell
Based on 37 analysts, 56.76% of analysts recommend a 'BUY' rating for Amgen Inc.. Average target price of $313.11
Get share price movements and forecasts by analysts on Amgen Inc..
What analysts predicted
-3.39%DOWNSIDE
Target Price
$313.11
Current Price
$323.74
Analyzed by
37 Analysts
Target
$313.11
Amgen Inc. target price $313.11, a slight downside of -3.39% compared to current price of $323.74. According to 37 analysts rating.
Search interest for Amgen Inc. Stock has increased by 26% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:26% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 08 November
Sat, 06:04 PM
-Amgen beats EPS by 128%, with revenues exceeding expectations by 6.6%, signaling strong performance.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Amgen Inc. has experienced consistent revenue growth over the last three quarters. Their revenue increased from $8.14 billion to $9.55 billion, reflecting an average increase of 7.6% per quarter.
Profit Spike
![]()
Amgen Inc. has shown a positive trend in its net profit over the last two quarters. The net profit increased from $1.43 billion to $3.21 billion, representing an average increase of 55.5% per quarter.
Price Rise
![]()
In the last 7 days, AMGN stock has moved up by 8.1%
Best in 3 Years
![]()
In the last 3 years, AMGN has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 1 year, Johnson & Johnson has given 20.0% return, outperforming this stock by 21.6%
| Organisation | Amgen Inc. |
| Headquarters | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 |
| Industry | Health Technology |
| CEO | Mr. Robert A. Bradway |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Casey Capparelli | Executive Director of Investor Relations |
Mr. Robert A. Bradway | Chairman, CEO & President |
Mr. Peter H. Griffith | Executive VP & CFO |
Dr. James E. Bradner M.D. | Executive Vice President of Research & Development |
Mr. Matthew C. Busch | Chief Accounting Officer & VP of Finance |
Mr. Scott Skellenger | Senior VP & Chief Information Officer |
Dr. David M. Reese M.D. | Executive VP & CTO |
Mr. Murdo Gordon | Executive Vice President of Global Commercial Operations |
Mr. Esteban Santos | Executive Vice President of Operations |
Mr. Howard Y. Chang M.D., Ph.D. | Senior VP of Global Research & Chief Scientific Officer |
Amgen Inc. share price today is $323.74 as on at the close of the market. Amgen Inc. share today touched a day high of $326.18 and a low of $319.54.
Amgen Inc. share touched a 52 week high of $335.88 on and a 52 week low of $253.3 on . Amgen Inc. stock price today i.e. is closed at $323.74,which is 3.61% down from its 52 week high and 27.81% up from its 52 week low.
Amgen Inc. market capitalisation is $0.17T as on .
Indian investors can start investing in Amgen Inc. (AMGN) shares with as little as ₹88.675 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.75 in Amgen Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Amgen Inc. share’s latest price of $323.74 as on November 11, 2025 at 2:29 am IST, you will get 0.0309 shares of Amgen Inc.. Learn more about
fractional shares .
Amgen Inc. stock has given 32.53% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?